DSIJ Mindshare

COVID Vaccine Sputnik V Manufacturer Hits Upper Circuit, Secures Rs 127 Crore Order from UNICEF – FIIs and DIIs Increase Stake

The company’s shares have delivered an impressive return of over 220 per cent in the past year.

Rakesh Deshmukh 0 77 Article rating: 5.0

In Q2FY25 the company reported a net profit of Rs 4.71 crore compared to a loss of Rs 8.29 crore

COVID Vaccine Sputnik V Manufacturing Stock Hits Upper Circuit Today, FIIs Increase Stake in Q1 – Stock Delivered Multibagger Return in Just 1 Month!

The company’s shares have delivered a multibagger return of over 140 per cent to its shareholders in just 6 months.

Rakesh Deshmukh 0 338 Article rating: 3.8

The world’s first registered COVID-19 vaccine, Sputnik V, earlier signed an agreement with the Russian Direct Investment Fund (RDIF) to manufacture 100 million doses per year.

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR